JMS Co.,Ltd.

TSE:7702 Stock Report

Market Cap: JP¥10.7b

JMSLtd Past Earnings Performance

Past criteria checks 0/6

JMSLtd's earnings have been declining at an average annual rate of -52.2%, while the Medical Equipment industry saw earnings growing at 6.2% annually. Revenues have been growing at an average rate of 3.4% per year.

Key information

-52.2%

Earnings growth rate

-52.2%

EPS growth rate

Medical Equipment Industry Growth7.8%
Revenue growth rate3.4%
Return on equity-0.1%
Net Margin-0.05%
Next Earnings Update07 Feb 2025

Recent past performance updates

Recent updates

JMSLtd's (TSE:7702) Dividend Will Be ¥8.50

Dec 25
JMSLtd's (TSE:7702) Dividend Will Be ¥8.50

JMSLtd's (TSE:7702) Dividend Will Be ¥8.50

Dec 11
JMSLtd's (TSE:7702) Dividend Will Be ¥8.50

JMSLtd (TSE:7702) Is Paying Out A Dividend Of ¥8.50

Sep 20
JMSLtd (TSE:7702) Is Paying Out A Dividend Of ¥8.50

JMSLtd (TSE:7702) Is Paying Out A Dividend Of ¥8.50

Aug 26
JMSLtd (TSE:7702) Is Paying Out A Dividend Of ¥8.50

JMSLtd (TSE:7702) Has Announced A Dividend Of ¥8.50

Aug 12
JMSLtd (TSE:7702) Has Announced A Dividend Of ¥8.50

JMSLtd (TSE:7702) Has Announced A Dividend Of ¥8.50

Jul 26
JMSLtd (TSE:7702) Has Announced A Dividend Of ¥8.50

JMSLtd (TSE:7702) Has Announced A Dividend Of ¥8.50

Jul 11
JMSLtd (TSE:7702) Has Announced A Dividend Of ¥8.50

JMSLtd's (TSE:7702) Dividend Will Be ¥8.50

Mar 04
JMSLtd's (TSE:7702) Dividend Will Be ¥8.50

Revenue & Expenses Breakdown

How JMSLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:7702 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2467,874-3612,7711,518
30 Jun 2466,86913212,5481,518
31 Mar 2465,292-3612,4451,518
31 Dec 2364,85720412,4591,318
30 Sep 2365,0139112,3381,318
30 Jun 2364,0595712,1521,318
31 Mar 2363,74028112,1231,318
31 Dec 2261,3187411,9021,531
30 Sep 2259,86926111,7541,531
30 Jun 2258,65342511,5761,531
31 Mar 2258,16982611,3731,531
31 Dec 2158,5981,19211,1791,600
30 Sep 2157,9531,17311,0981,600
30 Jun 2157,7961,44211,1421,600
31 Mar 2157,5781,73611,0311,600
31 Dec 2057,7662,22811,1251,417
30 Sep 2057,7512,40011,2361,417
30 Jun 2058,6542,58811,3381,417
31 Mar 2058,5691,97711,5541,417
31 Dec 1957,3601,35611,4211,515
30 Sep 1958,3511,37111,5521,515
30 Jun 1957,6171,18611,4421,515
31 Mar 1958,0591,16011,5051,515
31 Dec 1858,7881,11411,7491,553
30 Sep 1857,54484711,7231,553
30 Jun 1857,21641511,8731,553
31 Mar 1856,52063111,8091,553
31 Dec 1755,78450511,7541,462
30 Sep 1755,45098311,7131,462
30 Jun 1755,4781,33611,5391,462
31 Mar 1755,5741,18211,4861,462
31 Dec 1656,3141,20711,6651,258
30 Sep 1657,01587511,7181,258
30 Jun 1657,13182411,7741,258
31 Mar 1657,63675411,7741,258
31 Dec 1557,45056611,7661,215
30 Sep 1557,29935511,6571,215
30 Jun 1557,00640611,5181,215
31 Mar 1555,40113911,4301,215
31 Dec 1455,066-7911,2821,228
30 Sep 1454,3957911,1111,228
30 Jun 1453,606-5211,0791,228
31 Mar 1453,86020711,0841,228

Quality Earnings: 7702 is currently unprofitable.

Growing Profit Margin: 7702 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 7702 is unprofitable, and losses have increased over the past 5 years at a rate of 52.2% per year.

Accelerating Growth: Unable to compare 7702's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 7702 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.6%).

Return on Equity

High ROE: 7702 has a negative Return on Equity (-0.1%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 10:22
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

JMS Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCompany Forecast
Motoya KohtaniNomura Securities Co. Ltd.